Renee A Black

Title: Innovations in Influenza Detection by Inventor Renee A Black

Introduction

Renee A Black is an accomplished inventor based in Doraville, GA (US). She has made significant contributions to the field of virology, particularly in the detection of influenza viruses. Her innovative work has led to the development of a patented bioassay that enhances the diagnosis of influenza A and B infections.

Latest Patents

Renee A Black holds a patent for a bioassay for influenza A and B nucleoprotein. This invention relates to the nucleoprotein (NP) genes of the influenza A and B viruses, which were constructed from virion RNA. The NP genes were subsequently expressed in Spodoptera frugiperda (S19) cells using the baculovirus vector, Autographa californica nuclear polyhedrosis virus (AcNPV). The patent demonstrates that the baculovirus-expressed NP antigens are reactive with monoclonal antibodies specific for either type A or B NP and with anti-NP antibodies in human serum samples. The results indicate that these antigens can be used in routine assays for the serodiagnosis of influenza virus infections.

Career Highlights

Renee A Black has dedicated her career to advancing the field of infectious disease diagnostics. Her work has been instrumental in developing more efficient and reproducible methods for detecting influenza viruses. With her innovative approach, she has contributed to improving public health responses to influenza outbreaks.

Collaborations

Renee has collaborated with notable professionals in her field, including Paul A Rota. Their joint efforts have furthered research and development in the area of influenza diagnostics.

Conclusion

Renee A Black's contributions to the field of virology through her patented innovations have significantly enhanced the detection of influenza viruses. Her work exemplifies the impact of scientific research on public health.